FDAnews
www.fdanews.com/articles/173747-manhattan-scientifics-receives-chinese-patent-for-cancer-detection-platform

Manhattan Scientifics Receives Chinese Patent for Cancer Detection Platform

October 26, 2015

Manhattan Scientifics’ Senior Scientific has been granted a patent by the Chinese government covering the detection, measurement and imaging of cells such as cancer and other biologic substances using targeted nanoparticles and magnetic properties.

The patent is in addition to a similar patent awarded in the U.S. Senior Scientific COO Bob Proulx says having the company’s technology patent protected in both nations gives it the leverage to pursue global commercialization and licensing

The company is located in New Mexico, New York and Montreal and is focuses on technology transfer and commercialization in nano medicine. — John Bechtel